Skip to main content
Caplight Logo









Zoe Biosciences

Zoe Biosciences

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://zoebiosciences.com/

Last Round

Seed

Mar 31, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Zoe Biosciences is a biotechnology company developing best-in-class therapies to treat cardiometabolic disease by targeting molecular pathways linked to cellular senescence and metabolic dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

longevity biotechdrug discoverycardiometabolic diseasecellular senescencePAI-1 inhibitorsanti-aging therapeuticsgerosciencemonoclonal antibodiessmall molecule drugsAPJ agonistspreclinical biotechpharma licensinggenetic target validationmetabolic dysfunction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zoe Biosciences Comparables

Compare Zoe Biosciences with similar companies based on industry and business-model similarity.

Zoe Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rubedo Life Sciences
74%
Anodyne Nanotech
73%
BioAge Labs
73%

Zoe Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 31, 2023

Key People

Founding team and executive leadership

Scott Gies

CEO & Cofounder

Founding Team

Zoe Biosciences Investors

Notable investors and investment history

Zoe Biosciences investors
InvestorRounds
Longevitytech.fundPre Seed
VitaDAOSeed
Healthspan CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 41% MoM, reaching 1.6K.

  • Mar 2, 2026

    Monthly visitors grew 192% MoM, reaching 1.2K.

Zoe Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zoe Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zoe Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range2
Year Founded2021
Last FundingMar 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?